Dsm Capital Partners Boosted Abbott Laboratories (ABT) Holding; Gse Systems (NYSEMKT:GVP) Sellers Decreased By 38.83% Their Shorts

September 13, 2017 - By Maria Brooks

Dsm Capital Partners Llc increased Abbott Laboratories (ABT) stake by 501.48% reported in 2016Q4 SEC filing. Dsm Capital Partners Llc acquired 102,302 shares as Abbott Laboratories (ABT)’s stock declined 3.42%. The Dsm Capital Partners Llc holds 122,702 shares with $4.71M value, up from 20,400 last quarter. Abbott Laboratories now has $90.69 billion valuation. The stock declined 0.10% or $0.05 reaching $52.2 on the news. About 1.21M shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since September 13, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Gse Systems Incorporated (NYSEMKT:GVP) had a decrease of 38.83% in short interest. GVP’s SI was 12,600 shares in September as released by FINRA. Its down 38.83% from 20,600 shares previously. With 6,400 avg volume, 2 days are for Gse Systems Incorporated (NYSEMKT:GVP)’s short sellers to cover GVP’s short positions. The SI to Gse Systems Incorporated’s float is 0.1%. About 3,855 shares traded. GSE Systems, Inc. (NYSEMKT:GVP) has risen 61.21% since September 13, 2016 and is uptrending. It has outperformed by 44.51% the S&P500.

Dsm Capital Partners Llc decreased Alibaba Group Holding (NYSE:BABA) stake by 19,092 shares to 4.64 million valued at $407.17 million in 2016Q4. It also reduced Nxp Semiconductors (NASDAQ:NXPI) stake by 41,611 shares and now owns 1.38M shares. Adobe Systems (NASDAQ:ADBE) was reduced too.

Among 23 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Abbott Laboratories had 70 analyst reports since July 24, 2015 according to SRatingsIntel. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Thursday, July 20 with “Hold” rating. The stock of Abbott Laboratories (NYSE:ABT) earned “Market Perform” rating by William Blair on Friday, January 29. The firm earned “Buy” rating on Tuesday, August 15 by Cowen & Co. As per Tuesday, September 22, the company rating was initiated by UBS. The firm has “Buy” rating given on Thursday, August 4 by Jefferies. RBC Capital Markets maintained it with “Outperform” rating and $55 target in Thursday, July 23 report. On Tuesday, September 5 the stock rating was maintained by Jefferies with “Buy”. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Monday, June 26 with “Buy” rating. The rating was maintained by RBC Capital Markets on Friday, January 29 with “Outperform”. The company was upgraded on Tuesday, June 21 by Edward Jones.

Since March 31, 2017, it had 0 insider purchases, and 2 insider sales for $60,722 activity. Shares for $34,240 were sold by Contreras Jaime. 552 shares valued at $26,482 were sold by Watkin Jared on Thursday, June 15.

Investors sentiment decreased to 0.88 in Q4 2016. Its down 0.75, from 1.63 in 2016Q3. It fall, as 83 investors sold ABT shares while 496 reduced holdings. 103 funds opened positions while 481 raised stakes. 1.06 billion shares or 1.63% more from 1.04 billion shares in 2016Q3 were reported. Hedeker Wealth Limited Company invested in 0.88% or 27,987 shares. Hl Services Ltd Liability holds 0.27% in Abbott Laboratories (NYSE:ABT) or 328,990 shares. Grandfield & Dodd Limited holds 14,583 shares. Tower Cap Lc (Trc) has 0.17% invested in Abbott Laboratories (NYSE:ABT). Columbia Asset invested in 0.21% or 16,048 shares. Founders Capital Limited Liability Company owns 42,254 shares. Gotham Asset Management Lc invested in 0.5% or 1.01M shares. Engineers Gate Manager LP holds 0.46% or 111,938 shares. Dumont & Blake Invest Advisors Limited has 18,475 shares for 0.33% of their portfolio. Murphy Mngmt holds 12,706 shares. Legacy Cap Prns reported 1.43% stake. Rothschild Asset Management owns 470,090 shares or 0.23% of their US portfolio. Boyd Watterson Asset Mngmt Lc Oh, Ohio-based fund reported 47,094 shares. Meristem Llp stated it has 0.19% of its portfolio in Abbott Laboratories (NYSE:ABT). Cadence National Bank & Trust Na holds 50,006 shares or 0.9% of its portfolio.

GSE Systems, Inc. is a performance improvement company. The company has market cap of $54.84 million. The Firm operates through two divisions: Performance Improvement Solutions, and Nuclear Industry Training and Consulting. It has a 31.74 P/E ratio. The Performance Improvement Solutions segment provides simulation, training and engineering services and products to the industries, including nuclear and fossil fuel power industry, and chemical and petrochemical industries.

Investors sentiment decreased to 0.46 in Q4 2016. Its down 1.74, from 2.2 in 2016Q3. It fall, as 7 investors sold GSE Systems, Inc. shares while 7 reduced holdings. 1 funds opened positions while 4 raised stakes. 4.45 million shares or 7.69% less from 4.82 million shares in 2016Q3 were reported. Moreover, Vanguard has 0% invested in GSE Systems, Inc. (NYSEMKT:GVP). Bridgeway Capital Mngmt invested 0.01% of its portfolio in GSE Systems, Inc. (NYSEMKT:GVP). Northern Trust reported 0% stake. Blackrock Institutional Tru Na owns 45,583 shares. Blackrock Investment Mgmt Lc owns 2,666 shares for 0% of their portfolio. Bard Assoc owns 366,690 shares or 0.6% of their US portfolio. Vantage Lc invested in 0% or 95 shares. The Texas-based Eagle Glob Advisors Limited Com has invested 0% in GSE Systems, Inc. (NYSEMKT:GVP). Geode Capital Mgmt Ltd Liability Com owns 33,536 shares or 0% of their US portfolio. Renaissance Tech Llc reported 0% of its portfolio in GSE Systems, Inc. (NYSEMKT:GVP). Teton Advisors has invested 0.01% in GSE Systems, Inc. (NYSEMKT:GVP). Wells Fargo Mn has 0% invested in GSE Systems, Inc. (NYSEMKT:GVP). Panagora Asset Mgmt has invested 0% in GSE Systems, Inc. (NYSEMKT:GVP). Citigroup Inc holds 2,630 shares. S Squared Tech Ltd stated it has 3.07% of its portfolio in GSE Systems, Inc. (NYSEMKT:GVP).

Since June 7, 2017, it had 1 insider buy, and 1 insider sale for $2,657 activity. Abbott Paul had bought 5,356 shares worth $17,357 on Wednesday, June 7. Grady Gill R had sold 4,500 shares worth $14,700.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By : XYZScripts.com